Attenuation of Experimental Atherosclerosis by Interleukin-19.

Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

Bibtex

@article{711e33f2c28940d6a27b2097d188aba4,
title = "Attenuation of Experimental Atherosclerosis by Interleukin-19.",
abstract = "Interleukin-19 (IL-19) is a putative Th2, anti-inflammatory interleukin. Its expression and potential role in atherogenesis are unknown. IL-19 is not detected in normal artery and is expressed to a greater degree in plaque from symptomatic versus asymptomatic patients, suggesting a compensatory counter-regulatory function. We tested whether IL-19 could reduce atherosclerosis in susceptible mice and identified plausible mechanisms.",
author = "Stephen Ellison and Khatuna Gabunia and Kelemen, {Sheri E} and England, {Ross N} and Rosario Scalia and Richards, {James M} and Wayne Orr and Traylor, {James G} and Thomas Rogers and William Cornwell and Lisa Berglund and Isabel Goncalves and Maria Gomez and Autieri, {Michael V}",
year = "2013",
doi = "10.1161/ATVBAHA.113.301521",
language = "English",
volume = "33",
pages = "2316--2324",
journal = "Arteriosclerosis, Thrombosis and Vascular Biology",
issn = "1524-4636",
publisher = "Lippincott Williams Wilkins Hagerstown, MD",
number = "10",

}